GoHealth (GOCO) Stock Forecast, Price Target & Predictions
GOCO Stock Forecast
GoHealth stock forecast is as follows: an average price target of $13.00 (represents a 2.77% upside from GOCO’s last price of $12.65) and
GOCO Price Target
GoHealth Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 20, 2024 | Frank Morgan | RBC Capital | $13.00 | $10.16 | 27.95% | 2.77% |
The latest GoHealth stock forecast, released on Mar 20, 2024 by Frank Morgan from RBC Capital, set a price target of $13.00, which represents a 27.95% increase from the stock price at the time of the forecast ($10.16), and a 2.77% increase from GOCO last price ($12.65).
GoHealth Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $13.00 |
| Last Closing Price | $12.65 | $12.65 | $12.65 |
| Upside/Downside | -100.00% | -100.00% | 2.77% |
In the current month, the average price target of GoHealth stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to GoHealth's last price of $12.65. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
GoHealth Financial Forecast
GoHealth Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $276.70M | $132.04M | $142.78M | $183.16M | $69.38M | $133.05M | $158.65M | $270.59M | $245.14M | $211.73M | $196.90M | $204.18M | $445.92M | $163.36M | $127.06M |
| Avg Forecast | $149.72M | $144.62M | $139.70M | $134.94M | $353.67M | $119.06M | $119.39M | $184.01M | $325.78M | $106.92M | $141.79M | $180.15M | $363.88M | $138.25M | $116.36M | $184.98M | $358.04M | $146.78M | $133.90M | $159.99M | $527.64M | $199.36M | $178.64M | $175.37M | $436.40M | $168.88M | $124.30M |
| High Forecast | $149.72M | $144.62M | $139.70M | $134.94M | $353.67M | $119.06M | $119.39M | $184.01M | $325.78M | $112.82M | $141.79M | $180.15M | $364.25M | $138.25M | $116.36M | $184.98M | $358.04M | $146.78M | $133.90M | $159.99M | $527.64M | $199.36M | $178.64M | $175.37M | $436.40M | $168.88M | $124.30M |
| Low Forecast | $149.72M | $144.62M | $139.70M | $134.94M | $353.67M | $119.06M | $119.39M | $184.01M | $325.78M | $102.95M | $141.79M | $180.15M | $363.50M | $138.25M | $116.36M | $184.98M | $358.04M | $146.78M | $133.90M | $159.99M | $527.64M | $199.36M | $178.64M | $175.37M | $436.40M | $168.88M | $124.30M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.96% | 1.23% | 0.99% | 0.19% | 0.91% | 1.18% | 1.69% | 0.46% | 1.06% | 1.10% | 1.16% | 1.02% | 0.97% | 1.02% |
GoHealth's average Quarter revenue forecast for Mar 24 based on 1 analysts is $180.15M, with a low forecast of $180.15M, and a high forecast of $180.15M. GOCO's average Quarter revenue forecast represents a -34.89% decrease compared to the company's last Quarter revenue of $276.70M (Dec 23).
GoHealth EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $15.06M | $-37.98M | $-53.02M | $17.82M | $-109.30M | $-20.81M | $-49.62M | $577.00K | $-483.63M | $12.73M | $21.99M | $31.93M | $69.66M | $-22.95M | $10.62M |
| Avg Forecast | $-270.84K | $-261.61K | $-252.70K | $-244.09K | $-639.77K | $-215.38K | $-215.97K | $-332.86K | $-589.33K | $-193.41K | $-256.50K | $-325.89K | $-658.25K | $-250.09K | $-210.48K | $-334.62K | $-647.67K | $-265.52K | $-242.21K | $16.22M | $-954.48K | $-360.63K | $-323.15K | $35.13M | $-789.42K | $-305.49K | $9.79M |
| High Forecast | $-270.84K | $-261.61K | $-252.70K | $-244.09K | $-639.77K | $-215.38K | $-215.97K | $-332.86K | $-589.33K | $-186.24K | $-256.50K | $-325.89K | $-657.56K | $-250.09K | $-210.48K | $-334.62K | $-647.67K | $-265.52K | $-242.21K | $19.47M | $-954.48K | $-360.63K | $-323.15K | $42.15M | $-789.42K | $-305.49K | $11.75M |
| Low Forecast | $-270.84K | $-261.61K | $-252.70K | $-244.09K | $-639.77K | $-215.38K | $-215.97K | $-332.86K | $-589.33K | $-204.09K | $-256.50K | $-325.89K | $-658.92K | $-250.09K | $-210.48K | $-334.62K | $-647.67K | $-265.52K | $-242.21K | $12.98M | $-954.48K | $-360.63K | $-323.15K | $28.10M | $-789.42K | $-305.49K | $7.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -22.88% | 151.85% | 251.88% | -53.25% | 168.76% | 78.38% | 204.87% | 0.04% | 506.69% | -35.30% | -68.06% | 0.91% | -88.25% | 75.11% | 1.08% |
1 analysts predict GOCO's average Quarter EBITDA for Mar 24 to be $-325.89K, with a high of $-325.89K and a low of $-325.89K. This is -102.16% lower than GoHealth's previous annual EBITDA (Dec 23) of $15.06M.
GoHealth Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-1.23M | $-56.20M | $-70.23M | $-22.54M | $-150.74M | $-40.15M | $-43.82M | $-37.24M | $-439.59M | $-20.18M | $-11.99M | $-2.09M | $35.96M | $-56.42M | $-22.87M |
| Avg Forecast | $20.34M | $-34.01M | $-27.23M | $-6.48M | $11.37M | $-28.37M | $-25.16M | $-9.34M | $12.38M | $-30.37M | $-26.00M | $-9.84M | $21.12M | $-27.37M | $-29.10M | $-15.78M | $13.26M | $-42.94M | $-30.45M | $-8.99M | $31.32M | $-12.61M | $-7.31M | $-2.30M | $70.64M | $-2.22M | $-21.10M |
| High Forecast | $20.34M | $-34.01M | $-27.23M | $-6.48M | $11.37M | $-28.37M | $-25.16M | $-9.34M | $12.38M | $-25.61M | $-26.00M | $-9.84M | $21.97M | $-27.37M | $-29.10M | $-15.78M | $13.26M | $-42.94M | $-30.45M | $-7.19M | $31.32M | $-12.61M | $-7.31M | $-1.84M | $70.64M | $-2.22M | $-16.88M |
| Low Forecast | $20.34M | $-34.01M | $-27.23M | $-6.48M | $11.37M | $-28.37M | $-25.16M | $-9.34M | $12.38M | $-37.22M | $-26.00M | $-9.84M | $20.19M | $-27.37M | $-29.10M | $-15.78M | $13.26M | $-42.94M | $-30.45M | $-10.79M | $31.32M | $-12.61M | $-7.31M | $-2.76M | $70.64M | $-2.22M | $-25.32M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.06% | 2.05% | 2.41% | 1.43% | -11.36% | 0.94% | 1.44% | 4.14% | -14.04% | 1.60% | 1.64% | 0.91% | 0.51% | 25.41% | 1.08% |
GoHealth's average Quarter net income forecast for Mar 21 is $-2.30M, with a range of $-2.76M to $-1.84M. GOCO's average Quarter net income forecast represents a -106.39% decrease compared to the company's last Quarter net income of $35.96M (Dec 20).
GoHealth SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $100.24M | $52.38M | $77.12M | $68.36M | $81.82M | $48.27M | $82.82M | $113.25M | $125.22M | $183.21M | $154.90M | $130.89M | $185.90M | $311.81M | $66.09M |
| Avg Forecast | $54.36M | $52.51M | $50.72M | $49.00M | $128.42M | $43.23M | $43.35M | $66.81M | $118.29M | $38.82M | $51.49M | $65.41M | $132.13M | $50.20M | $42.25M | $67.17M | $130.01M | $53.30M | $48.62M | $136.31M | $191.59M | $72.39M | $64.86M | $143.98M | $158.46M | $61.32M | $60.97M |
| High Forecast | $54.36M | $52.51M | $50.72M | $49.00M | $128.42M | $43.23M | $43.35M | $66.81M | $118.29M | $40.97M | $51.49M | $65.41M | $132.26M | $50.20M | $42.25M | $67.17M | $130.01M | $53.30M | $48.62M | $163.57M | $191.59M | $72.39M | $64.86M | $172.77M | $158.46M | $61.32M | $73.17M |
| Low Forecast | $54.36M | $52.51M | $50.72M | $49.00M | $128.42M | $43.23M | $43.35M | $66.81M | $118.29M | $37.38M | $51.49M | $65.41M | $131.99M | $50.20M | $42.25M | $67.17M | $130.01M | $53.30M | $48.62M | $109.05M | $191.59M | $72.39M | $64.86M | $115.18M | $158.46M | $61.32M | $48.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 1.04% | 1.83% | 1.02% | 0.63% | 0.91% | 1.70% | 0.83% | 0.65% | 2.53% | 2.39% | 0.91% | 1.17% | 5.09% | 1.08% |
GoHealth's average Quarter SG&A projection for Mar 24 is $65.41M, based on 1 Wall Street analysts, with a range of $65.41M to $65.41M. The forecast indicates a -34.74% fall compared to GOCO last annual SG&A of $100.24M (Dec 23).
GoHealth EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.13 | $-5.92 | $-7.70 | $-2.51 | $-16.95 | $-4.55 | $-5.28 | $-4.81 | $-57.32 | $-2.66 | $-1.76 | $-0.34 | $1.68 | $-10.05 | $-4.24 |
| Avg Forecast | $2.04 | $-3.41 | $-2.73 | $-0.65 | $1.14 | $-2.85 | $-2.52 | $-0.94 | $1.24 | $-3.04 | $-2.61 | $-0.99 | $2.12 | $-2.74 | $-2.92 | $-1.58 | $1.33 | $-4.31 | $-3.05 | $-1.27 | $3.14 | $-1.26 | $-0.73 | $-0.06 | $7.08 | $-0.22 | $-0.54 |
| High Forecast | $2.04 | $-3.41 | $-2.73 | $-0.65 | $1.14 | $-2.85 | $-2.52 | $-0.94 | $1.24 | $-2.57 | $-2.61 | $-0.99 | $2.20 | $-2.74 | $-2.92 | $-1.58 | $1.33 | $-4.31 | $-3.05 | $-1.27 | $3.14 | $-1.26 | $-0.73 | $-0.06 | $7.08 | $-0.22 | $-0.54 |
| Low Forecast | $2.04 | $-3.41 | $-2.73 | $-0.65 | $1.14 | $-2.85 | $-2.52 | $-0.94 | $1.24 | $-3.73 | $-2.61 | $-0.99 | $2.02 | $-2.74 | $-2.92 | $-1.58 | $1.33 | $-4.31 | $-3.05 | $-1.27 | $3.14 | $-1.26 | $-0.73 | $-0.06 | $7.08 | $-0.22 | $-0.54 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.06% | 2.16% | 2.64% | 1.59% | -12.74% | 1.06% | 1.73% | 3.79% | -18.25% | 2.10% | 2.40% | 5.28% | 0.24% | 45.16% | 7.92% |
According to 1 Wall Street analysts, GoHealth's projected average Quarter EPS for Mar 21 is $-0.06, with a low estimate of $-0.06 and a high estimate of $-0.06. This represents a -103.83% decrease compared to GOCO previous annual EPS of $1.68 (Dec 20).
GoHealth Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EHTH | eHealth | $5.00 | $7.00 | 40.00% | Buy |
| SLQT | SelectQuote | $2.03 | $2.17 | 6.90% | Buy |
| GOCO | GoHealth | $12.65 | $13.00 | 2.77% | - |
| WTW | Willis Towers Watson Public Limited Company | $302.82 | $292.50 | -3.41% | Buy |
| BRP | Baldwin Insurance Group | $32.66 | $31.00 | -5.08% | Buy |
| AON | Aon | $365.64 | $343.85 | -5.96% | Hold |
| MMC | Marsh & McLennan Companies | $221.16 | $199.35 | -9.86% | Hold |
| AJG | Arthur J. Gallagher | $281.65 | $252.73 | -10.27% | Buy |
| BRO | Brown & Brown | $105.45 | $93.30 | -11.52% | Buy |
GOCO Forecast FAQ
Will GoHealth stock go up soon?
According to Wall Street analysts' prediction for GOCO stock, the company can go up by 2.77% (from the last price of $12.65 to the average price target of $13), up by 2.77% based on the highest stock price target, and up by 2.77% based on the lowest stock price target.
Can GoHealth stock reach $20?
GOCO's average twelve months analyst stock price target of $13 does not support the claim that GoHealth can reach $20 in the near future.
What are GoHealth's analysts' financial forecasts?
GoHealth's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $776.12M (high $776.12M, low $776.12M), average EBITDA is $-1.404M (high $-1.404M, low $-1.404M), average net income is $-51.511M (high $-51.511M, low $-51.511M), average SG&A $281.81M (high $281.81M, low $281.81M), and average EPS is $-5.165 (high $-5.165, low $-5.165). GOCO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $568.98M (high $568.98M, low $568.98M), average EBITDA is $-1.029M (high $-1.029M, low $-1.029M), average net income is $-47.372M (high $-47.372M, low $-47.372M), average SG&A $206.6M (high $206.6M, low $206.6M), and average EPS is $-4.75 (high $-4.75, low $-4.75).
Did the GOCO's actual financial results beat the analysts' financial forecasts?
Based on GoHealth's last annual report (Dec 2023), the company's revenue was $734.67M, which missed the average analysts forecast of $803.47M by -8.56%. Apple's EBITDA was $-81.681M, beating the average prediction of $-1.453M by 5519.83%. The company's net income was $-151M, beating the average estimation of $-51.126M by 195.88%. Apple's SG&A was $298.11M, beating the average forecast of $291.74M by 2.18%. Lastly, the company's EPS was $-16.28, beating the average prediction of $-5.126 by 217.57%. In terms of the last quarterly report (Dec 2023), GoHealth's revenue was $276.7M, missing the average analysts' forecast of $363.88M by -23.96%. The company's EBITDA was $15.06M, missing the average prediction of $-658K by -2387.89%. GoHealth's net income was $-1.226M, missing the average estimation of $21.12M by -105.80%. The company's SG&A was $100.24M, missing the average forecast of $132.13M by -24.13%. Lastly, the company's EPS was $-0.13, missing the average prediction of $2.12 by -106.14%